A review of 262 randomized trials involving nearly 100,000 adults found that obesity medications vary substantially in weight loss, adverse effects, cardiovascular outcomes, and treatment discontinuation.
Tirzepatide and CagriSema produced the largest estimated weight reductions at one year, but injectable semaglutide had the clearest evidence for reduc…
